Patrick Phelps2026-06-01T13:34:17+00:00SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic CancerPatrick Phelps2026-06-01T13:34:17+00:0011, Feb 2026|
Patrick Phelps2026-01-27T14:57:34+00:00SOFIE drives U.S. manufacture of [18F]FAPI-74Patrick Phelps2026-01-27T14:57:34+00:0027, Jan 2026|
sofie_c557hm2026-01-23T00:27:04+00:00SOFIE’s Phase 2 FAPI Study Outcomes Showcased at ASCO GI 2026sofie_c557hm2026-01-23T00:27:04+00:0023, Jan 2026|
Patrick Phelps2025-12-29T13:07:36+00:00SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 StudyPatrick Phelps2025-12-29T13:07:36+00:0029, Dec 2025|
Patrick Phelps2025-12-12T18:06:28+00:00SOFIE activates FAPI-PRO, second [18F]FAPI-74 Phase 3 trialPatrick Phelps2025-12-12T18:06:28+00:0012, Dec 2025|
Patrick Phelps2025-11-17T16:54:53+00:00SOFIE activates FAPI-GO, first [18F]FAPI-74 Phase 3 trialPatrick Phelps2025-11-17T16:54:53+00:0017, Nov 2025|
